CN104278022B - A kind of preparation method and application of DNA capture probes - Google Patents
A kind of preparation method and application of DNA capture probes Download PDFInfo
- Publication number
- CN104278022B CN104278022B CN201410464934.0A CN201410464934A CN104278022B CN 104278022 B CN104278022 B CN 104278022B CN 201410464934 A CN201410464934 A CN 201410464934A CN 104278022 B CN104278022 B CN 104278022B
- Authority
- CN
- China
- Prior art keywords
- dna
- preparation
- magnetic bead
- capture probes
- biotin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000523 sample Substances 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 229960002685 biotin Drugs 0.000 claims abstract description 26
- 239000011616 biotin Substances 0.000 claims abstract description 26
- 238000002372 labelling Methods 0.000 claims abstract description 8
- 108020004414 DNA Proteins 0.000 claims description 53
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 48
- 239000011324 bead Substances 0.000 claims description 43
- 235000020958 biotin Nutrition 0.000 claims description 24
- 108090001008 Avidin Proteins 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 17
- 238000001821 nucleic acid purification Methods 0.000 claims description 15
- 238000012163 sequencing technique Methods 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 108020005196 Mitochondrial DNA Proteins 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 238000000527 sonication Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 238000013467 fragmentation Methods 0.000 claims 8
- 238000006062 fragmentation reaction Methods 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 5
- 235000011121 sodium hydroxide Nutrition 0.000 claims 2
- 238000002604 ultrasonography Methods 0.000 claims 2
- 238000011534 incubation Methods 0.000 claims 1
- 230000003321 amplification Effects 0.000 abstract description 10
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 10
- 230000015572 biosynthetic process Effects 0.000 abstract description 9
- 238000003786 synthesis reaction Methods 0.000 abstract description 9
- 239000012634 fragment Substances 0.000 description 20
- 239000000047 product Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000009210 therapy by ultrasound Methods 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- 108020003215 DNA Probes Proteins 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000012268 mitochondrial disease Diseases 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 238000007480 sanger sequencing Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 2
- 238000012070 whole genome sequencing analysis Methods 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明提供一种DNA捕获探针的制备方法及应用,采用了扩增目的基因‑随机打断‑生物素标记的探针制备方法,利用随机覆盖的设计思路取代了传统的瓦片式覆盖,与传统探针制备方法中合成大量DNA覆盖目标区域相比,本发明仅需合成目标区域的扩增引物,避免了直接合成探针造成的成本上升问题,因而大大降低了制备成本且捕获的灵敏性与特异性与传统探针制备方法制备的探针相比没有差异。The present invention provides a preparation method and application of a DNA capture probe, which adopts a probe preparation method for amplifying a target gene-randomly interrupting-biotin labeling, and replaces the traditional tile-type covering with the design idea of random covering, Compared with the synthesis of a large amount of DNA covering the target region in the traditional probe preparation method, the present invention only needs to synthesize the amplification primers of the target region, avoiding the cost increase problem caused by the direct synthesis of probes, thus greatly reducing the preparation cost and capturing sensitive There is no difference in the specificity and specificity compared with the probe prepared by the traditional probe preparation method.
Description
技术领域technical field
本发明属于核酸探针制备领域,具体涉及一种DNA捕获探针的制备方法及应用。The invention belongs to the field of nucleic acid probe preparation, and in particular relates to a preparation method and application of a DNA capture probe.
背景技术Background technique
传统桑格测序利用DNA聚合酶来延伸结合在待定序列模板上的引物,直到掺入一种链终止核苷酸为止。每个反应含有所有四种脱氧核苷酸三磷酸(dNTP),并混入限量的不同颜色荧光标记的双脱氧核苷三磷酸(ddNTP)。由于ddNTP缺乏延伸所需要的3-OH基团,使延长的寡聚核苷酸选择性地在G、A、T或C处终止。终止点由反应中相应的双脱氧而定。它们具有共同的起始点,但终止在不同的的核苷酸上,可通过毛细管电泳分离大小不同的片段,观察不同大小片度的荧光标记来推断序列。Traditional Sanger sequencing utilizes a DNA polymerase to extend a primer bound to a template to be sequenced until a chain-terminating nucleotide is incorporated. Each reaction contains all four deoxynucleotide triphosphates (dNTPs) mixed with limited amounts of fluorescently labeled dideoxynucleoside triphosphates (ddNTPs) of different colors. Since ddNTPs lack the 3-OH group required for elongation, elongated oligonucleotides are selectively terminated at G, A, T, or C. The termination point is determined by the corresponding dideoxygen in the reaction. They have a common starting point, but end at different nucleotides. Fragments of different sizes can be separated by capillary electrophoresis, and the sequence can be deduced by observing fluorescent labels of different sizes.
第二代测序技术主要采用边合成边测序的方法,首先利用超声波把待测的DNA样本打断成小片段,并在这些小片段的两端添加上不同的接头,构建出单链DNA文库。这些文库中的接头附着在固相表面,并在表面进行桥式PCR扩增。经过不断的扩增和变性循环,最终每个DNA片段都在各自位置上集中成束,每一个束都含有单个DNA模板的很多份拷贝,进行这一过程的目的在于实现将碱基的信号强度放大,以达到测序所需的信号要求。测序反应过程中,向反应体系中同时添加DNA聚合酶、接头引物和带有碱基特异荧光标记的4种dNTP(如同Sanger测序法)。这些dNTP的3’-OH被化学方法所保护,因而每次只能添加一个dNTP。在dNTP被添加到合成链上后,所有未使用的游离dNTP和DNA聚合酶会被洗脱掉。接着,再加入激发荧光所需的缓冲液,用激光激发荧光信号,并由光学设备完成荧光信号的记录,最后利用计算机分析将光学信号转化为测序碱基。这样荧光信号记录完成后,再加入化学试剂淬灭荧光信号并去除dNTP 3’-OH保护基团,以便能进行下一轮的测序反应。The second-generation sequencing technology mainly adopts the method of sequencing while synthesizing. First, the DNA sample to be tested is broken into small fragments by ultrasonic waves, and different adapters are added to the two ends of these small fragments to construct a single-stranded DNA library. The adapters in these libraries are attached to a solid surface and bridge PCR amplification is performed on the surface. After continuous amplification and denaturation cycles, each DNA fragment is finally concentrated into a bundle at its own position, and each bundle contains many copies of a single DNA template. The purpose of this process is to achieve the signal intensity of the base Amplify to achieve the signal requirements required for sequencing. During the sequencing reaction, DNA polymerase, adapter primers, and four kinds of dNTPs with base-specific fluorescent labels are simultaneously added to the reaction system (as in the Sanger sequencing method). The 3'-OH of these dNTPs are chemically protected so that only one dNTP can be added at a time. After the dNTPs are added to the synthetic strand, all unused free dNTPs and DNA polymerase are eluted. Next, add the buffer required to excite fluorescence, use laser to excite the fluorescence signal, and complete the recording of the fluorescence signal by optical equipment, and finally use computer analysis to convert the optical signal into sequencing bases. In this way, after the fluorescent signal recording is completed, chemical reagents are added to quench the fluorescent signal and remove the dNTP 3'-OH protecting group, so that the next round of sequencing reaction can be performed.
自2005年诞生以来,第二代测序技术展示了广阔的应用前景。通过测序科学家可以看到单核苷酸多态性、突变热点、基因组结构变异、群体多态性等重要信息。在进化领域科学家通过群体多态性分析探索物种之间的进化模式;在微生物领域DNA测序分型已被证明快捷而准确;而在医学领域基因组重测序在发现SNP与重大疾病的关系方面有着重要的意义。Since its birth in 2005, the second-generation sequencing technology has shown broad application prospects. Through sequencing, scientists can see important information such as single nucleotide polymorphisms, mutation hotspots, genome structural variations, and population polymorphisms. In the field of evolution, scientists explore the evolutionary patterns between species through population polymorphism analysis; in the field of microorganisms, DNA sequencing typing has been proved to be fast and accurate; and in the field of medicine, genome resequencing plays an important role in discovering the relationship between SNPs and major diseases meaning.
由于往往只对基因组特定区域(比如外显子组)而不是全基因组感兴趣,因此会利用基因捕获探针对特定的区域进行捕获,对捕获出的DNA序列进行测序。探针制备是捕获测序中关键环节,目前常用的探针制备方法主要采取“瓦片式覆盖设计,人工合成碱基”的方式。具体方法是:针对感兴趣的区域设计一定长度的探针序列,每个序列沿着基因位置移动一定距离。然后采用人工合成的方式大量合成上述序列。典型的代表有中国专利《一种线粒体病基因的筛查方法》(CN 101270390 A),针对感兴趣的区域中的非重复区域设计60bp的探针序列,每个序列沿着基因位置挪动设计,探针之间挪动3bp,实现对目标区域的瓦片式覆盖;然后采用原位合成技术大量合成探针。另外文献[Calvo SE,Compton AG,HershmanSG,Lim SC,Lieber DS,Tucker EJ,Laskowski A,Garone C,Liu S,Jaffe DB et al:Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing.Science translational medicine 2012,4(118):118ra110]中也采用了类似的思路,只是探针长度和挪动距离有所改变。Since we are often only interested in a specific region of the genome (such as the exome) rather than the whole genome, we use gene capture probes to capture specific regions and sequence the captured DNA sequences. Probe preparation is a key link in capture sequencing. The current commonly used probe preparation method mainly adopts the method of "tile coverage design and artificial base synthesis". The specific method is: design a certain length of probe sequence for the region of interest, and each sequence moves a certain distance along the gene position. Then, the above-mentioned sequences were synthesized in large quantities by means of artificial synthesis. A typical representative is the Chinese patent "A Screening Method for Mitochondrial Disease Genes" (CN 101270390 A). A 60bp probe sequence is designed for the non-repeated region in the region of interest, and each sequence is designed by moving along the gene position. Move 3bp between the probes to achieve tile-like coverage of the target area; then use in situ synthesis technology to synthesize a large number of probes. Other literature [Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, Tucker EJ, Laskowski A, Garone C, Liu S, Jaffe DB et al: Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Science translational medicine 2012,4(118):118ra110] also adopted a similar idea, but the probe length and moving distance were changed.
“瓦片式覆盖设计,人工合成碱基”方法最大的缺陷是成本过于高昂,且随着目标区域的增大,探针合成成本急剧上升。The biggest drawback of the "tile coverage design, artificially synthesized bases" method is that the cost is too high, and with the increase of the target area, the cost of probe synthesis rises sharply.
发明内容Contents of the invention
本发明的目的在于提供一种DNA捕获探针的制备方法及应用,可以降低探针制备成本。The purpose of the present invention is to provide a preparation method and application of a DNA capture probe, which can reduce the cost of probe preparation.
为达到上述目的,本发明采用了以下技术方案。In order to achieve the above object, the present invention adopts the following technical solutions.
一种DNA捕获探针的制备方法,包括以下步骤:A method for preparing a DNA capture probe, comprising the following steps:
(1)针对基因组中感兴趣区域设计特异的扩增引物,利用扩增引物扩增所述感兴趣区域得扩增产物;(1) Design specific amplification primers for regions of interest in the genome, and use the amplification primers to amplify the regions of interest to obtain amplification products;
(2)采用超声处理的方法将所述扩增产物打断为DNA片段;(2) fragmenting the amplified product into DNA fragments by ultrasonic treatment;
(3)对DNA片段进行生物素标记;(3) carry out biotin labeling to DNA fragment;
(4)经过步骤(3)后,从所述DNA片段中分离得到标记有生物素的DNA单链,得DNA捕获探针。(4) After step (3), the DNA single strand labeled with biotin is separated from the DNA fragment to obtain a DNA capture probe.
所述感兴趣区域为人线粒体DNA。The region of interest is human mitochondrial DNA.
所述步骤(2)具体包括以下步骤:将扩增产物(回收的人线粒体DNA扩增产物)稀释至10ng/L,然后取100L稀释后的扩增产物放入超声仪中进行超声处理,超声仪的输出功率为1000Hz,超声处理次数为90次,单次超声处理时间为15秒,两次超声处理间间隔15秒。The step (2) specifically includes the following steps: diluting the amplification product (recovered human mitochondrial DNA amplification product) to 10 ng/L, then taking 100 L of the diluted amplification product and putting it into an ultrasonic instrument for ultrasonic treatment, ultrasonic The output power of the instrument is 1000Hz, the number of ultrasonic treatment is 90 times, the time of single ultrasonic treatment is 15 seconds, and the interval between two ultrasonic treatments is 15 seconds.
进行生物素标记前,对步骤(2)得到的DNA片段按照片段大小进行纯化,然后进行生物素标记,所述纯化的方法包括以下步骤:向经过步骤(2)处理的100L 10ng/L扩增产物中加入核酸纯化磁珠(Ampure bead)后进行混匀,然后静置5min;静置后置于磁架上,待核酸纯化磁珠被吸附后,吸弃上清;然后用70%乙醇洗涤核酸纯化磁珠,洗涤后晾干核酸纯化磁珠,用水重悬晾干后的核酸纯化磁珠后置于磁架上,待核酸纯化磁珠被吸附后,转移上清,该上清中含有纯化后的DNA片段。Before carrying out biotin labeling, the DNA fragment obtained in step (2) is purified according to the size of the fragment, and then biotin-labeled. The purification method includes the following steps: amplify to 100L 10ng/L treated by step (2) Add nucleic acid purification magnetic beads (Ampure bead) to the product, mix well, and then let it stand for 5 minutes; after standing still, place it on a magnetic rack. After the nucleic acid purification magnetic beads are absorbed, discard the supernatant; then wash with 70% ethanol Nucleic acid purification magnetic beads, after washing, dry the nucleic acid purification magnetic beads, resuspend the dried nucleic acid purification magnetic beads in water and place them on the magnetic rack. After the nucleic acid purification magnetic beads are absorbed, transfer the supernatant, which contains Purified DNA fragments.
所述核酸纯化磁珠的加入量为90L(核酸纯化磁珠的加入量决定回收的DNA片段的大小),70%乙醇的用量为每次洗涤使用500~750L。The added amount of the nucleic acid purification magnetic beads is 90L (the added amount of the nucleic acid purification magnetic beads determines the size of the recovered DNA fragments), and the consumption of 70% ethanol is 500-750L for each washing.
所述步骤(4)具体包括以下步骤:Described step (4) specifically comprises the following steps:
(a)用亲和素包被的磁珠(invitrogen)吸附生物素标记成功的DNA片段;(a) Adsorb the successfully biotin-labeled DNA fragments with avidin-coated magnetic beads (invitrogen);
(b)经过步骤(a)后,用氢氧化钠水溶液洗涤所述亲和素包被的磁珠,将所述DNA片段中未标记生物素的DNA单链从所述亲和素包被的磁珠上去除;(b) After step (a), the magnetic beads coated with avidin are washed with aqueous sodium hydroxide solution, and the single-strand DNA of unlabeled biotin in the DNA fragment is separated from the avidin-coated magnetic beads removal on magnetic beads;
(c)经过步骤(b)后,用去离子甲酰胺重悬所述亲和素包被的磁珠并于95℃加热10min,使所述生物素与所述亲和素分离,然后分离得到标记有生物素的DNA单链。(c) After step (b), resuspend the avidin-coated magnetic beads with deionized formamide and heat at 95°C for 10 minutes to separate the biotin from the avidin, and then separate to obtain Single-stranded DNA labeled with biotin.
所述氢氧化钠水溶液的浓度为1.25mM(碱性太强或太弱均无法达到洗涤的目的)。The concentration of the sodium hydroxide aqueous solution is 1.25mM (the alkalinity is too strong or too weak to achieve the purpose of washing).
上述DNA捕获探针的制备方法制备的DNA捕获探针在从人全基因组测序文库中捕获人线粒体DNA文库的应用。The application of the DNA capture probe prepared by the method for preparing the DNA capture probe described above is used to capture a human mitochondrial DNA library from a human whole genome sequencing library.
DNA捕获探针的用量为所述测序文库质量的2~2.5%。The amount of the DNA capture probe is 2-2.5% of the mass of the sequencing library.
本发明的有益效果体现在:The beneficial effects of the present invention are reflected in:
本发明采用了扩增目的基因-随机打断-生物素标记的探针制备方法,利用随机覆盖的设计思路取代了传统的瓦片式覆盖,与传统探针制备方法中合成大量DNA覆盖目标区域相比,本发明仅需合成目标区域的扩增引物,避免了直接合成探针造成的成本上升问题,因而大大降低了制备成本且捕获的灵敏性与特异性与传统探针制备方法制备的探针相比没有差异。The present invention adopts the probe preparation method of amplifying the target gene-random interruption-biotin labeling, replaces the traditional tile-type coverage with the design idea of random coverage, and synthesizes a large amount of DNA to cover the target area with the traditional probe preparation method In contrast, the present invention only needs to synthesize the amplification primers of the target region, avoiding the cost increase problem caused by direct synthesis of probes, thus greatly reducing the preparation cost and the sensitivity and specificity of capture are comparable to those of probes prepared by traditional probe preparation methods. There is no difference compared to the needle.
附图说明Description of drawings
图1为本发明制备的人线粒体DNA捕获探针的捕获效果图,其中,A-D行:本发明制备探针的捕获效果(四次重复),E行:采用传统方法制备的探针的捕获效果。Fig. 1 is the capture effect diagram of the human mitochondrial DNA capture probe prepared by the present invention, wherein, A-D line: the capture effect of the probe prepared by the present invention (four repetitions), E line: the capture effect of the probe prepared by traditional method .
具体实施方式detailed description
下面结合附图和实施例对本发明作详细说明。The present invention will be described in detail below in conjunction with the accompanying drawings and embodiments.
(一)人线粒体DNA捕获探针的制备方法,包括以下步骤:(1) The preparation method of human mitochondrial DNA capture probe comprises the following steps:
1.以三对引物(1F和1R,2F和2R,3F和3R)扩增线粒体DNA全长序列;1. Amplify the full-length mitochondrial DNA sequence with three pairs of primers (1F and 1R, 2F and 2R, 3F and 3R);
所述扩增的条件为:The conditions for the amplification are:
(1)PCR反应体系:(1) PCR reaction system:
所用DNA聚合酶为东洋纺KOD FX,货号KFX-101。The DNA polymerase used is Toyobo KOD FX, product number KFX-101.
反应体系:reaction system:
(2)PCR反应程序为:94℃预变性2 min;94℃变性30 s,60℃退火30 s,72℃延伸8min;40个循环;72℃延伸15 min。(2) The PCR reaction program was: pre-denaturation at 94°C for 2 min; denaturation at 94°C for 30 s, annealing at 60°C for 30 s, extension at 72°C for 8 min; 40 cycles; extension at 72°C for 15 min.
所述引物的序列如表1所示:The sequences of the primers are shown in Table 1:
表1Table 1
2.将三对引物的扩增产物等摩尔混匀,用超声仪打断成约200bp的片段;2. Mix the amplification products of the three pairs of primers equimolarly, and break them into fragments of about 200bp with an ultrasonic instrument;
超声处理的步骤以及条件为:The steps and conditions of ultrasonic treatment are:
将回收的PCR产物(三对引物的产物混合物)稀释至10ng/L;The recovered PCR product (the product mixture of three pairs of primers) was diluted to 10ng/L;
稀释后取100L加入EP管中,然后使用宁波新芝98-Ⅱ杯式超声仪进行超声处理,调整输出功率为1000Hz,15秒on,15秒off,90次反应;After dilution, take 100L and add it to the EP tube, then use Ningbo Xinzhi 98-Ⅱ cup ultrasonic instrument for ultrasonic treatment, adjust the output power to 1000Hz, 15 seconds on, 15 seconds off, 90 reactions;
超声处理后向EP管中加入0.9倍体积(90L)贝克曼库尔特的Ampure bead,充分混匀后,静置5min;After sonication, add 0.9 times the volume (90L) of Beckman Coulter's Ampure bead to the EP tube, mix thoroughly, and let stand for 5 minutes;
然后略微离心(实验室用掌上离心机,无转速和时间要求,只要能将粘在管壁和盖子上的液体甩到管底即可,此操作术语为spin-down),离心后将EP管置于磁架,待磁珠(Ampure bead)被充分吸附后,吸弃上清;Then centrifuge slightly (the hand-held centrifuge used in the laboratory has no speed and time requirements, as long as the liquid sticking to the tube wall and cover can be thrown to the bottom of the tube, the term for this operation is spin-down), after centrifugation, the EP tube Place on a magnetic rack, and discard the supernatant after the magnetic beads (Ampure bead) are fully adsorbed;
然后加入700L 70%乙醇洗涤磁珠(Ampure bead)两次(EP管不从磁架上取下),洗涤后晾干磁珠;Then add 700L 70% ethanol to wash the magnetic beads (Ampure bead) twice (the EP tube is not removed from the magnetic rack), and dry the magnetic beads after washing;
然后向EP管中加入16L水,充分重悬磁珠(Ampure bead);Then add 16L of water to the EP tube to fully resuspend the magnetic beads (Ampure bead);
然后将EP管置于磁架,待磁珠(Ampure bead)被充分吸附后,转移上清(含有的DNA片段的大小约为200bp)至新的PCR管中保存;Then place the EP tube on the magnetic rack, and after the magnetic beads (Ampure bead) are fully adsorbed, transfer the supernatant (the size of the DNA fragment contained is about 200bp) to a new PCR tube for storage;
3.对打断后的片段进行生物素标记;3. Biotin-label the interrupted fragments;
参考罗氏High Prime产品使用说明书。货号1585649。Refer to Roche High Prime Product Instructions for Use. Item No. 1585649.
将PCR管中大小约为200bp的DNA片段于95℃变性5min后,迅速插入冰上;完全冷却后,加入4L Biotin-high prime,充分混匀,37℃孵育过夜。Denature the DNA fragment with a size of about 200bp in the PCR tube at 95°C for 5 minutes, and quickly insert it on ice; after cooling completely, add 4L Biotin-high prime, mix well, and incubate overnight at 37°C.
4.用100L亲和素包被的磁珠分离生物素标记成功的DNA片段;(此时生物素标记的DNA片段结合在亲和素包被的磁珠上)。4. Use 100L of avidin-coated magnetic beads to separate biotin-labeled DNA fragments; (at this time, the biotin-labeled DNA fragments are bound to the avidin-coated magnetic beads).
5.以1.25mM氢氧化钠水溶液50L洗涤结合有DNA片段的亲和素包被的磁珠,去掉未标记的单链;(此时亲和素包被的磁珠上结合的是生物素标记的DNA单链)5. Wash the avidin-coated magnetic beads bound with DNA fragments with 50 L of 1.25 mM sodium hydroxide aqueous solution to remove unlabeled single strands; (at this time, biotin-labeled beads are bound to the avidin-coated magnetic beads DNA single strand)
6.以去离子甲酰胺100L重悬磁珠,95℃加热10min,使生物素与亲和素分离(即标记有生物素的DNA单链从亲和素包被的磁珠上脱附);6. Resuspend the magnetic beads in 100L of deionized formamide, and heat at 95°C for 10 minutes to separate the biotin from the avidin (that is, the DNA single strand labeled with biotin is desorbed from the avidin-coated magnetic beads);
7.Qiagen minElute试剂盒纯化6中所述体系中的DNA,所得产物即为生物素标记的DNA探针,约3g,即捕获探针。7. The Qiagen minElute kit was used to purify the DNA in the system described in 6, and the resulting product was a biotin-labeled DNA probe, about 3 g, which was the capture probe.
8.用生物素标记的DNA探针从人全基因组测序文库中捕获人线粒体DNA文库,具体如下:8. Capture the human mitochondrial DNA library from the human whole genome sequencing library with a biotin-labeled DNA probe, specifically as follows:
本探针所捕获对象为已构建完成的高通量测序文库;The target captured by this probe is the constructed high-throughput sequencing library;
将制备好的探针(测序文库质量的2~2.5%)与100~500ng测序文库混匀,在PCR反应缓冲液条件下杂交24h;Mix the prepared probe (2-2.5% of the mass of the sequencing library) with 100-500ng of the sequencing library, and hybridize for 24 hours under the condition of PCR reaction buffer;
加入亲和素包被的磁珠,使亲和素与生物素充分结合;Add avidin-coated magnetic beads to fully combine avidin and biotin;
用wash buffer洗掉非特异结合的文库;Use wash buffer to wash away the non-specific binding library;
加入1.25mM NaOH水溶液,使被捕获的文库双链分离,并回收洗下的单链文库;Add 1.25mM NaOH aqueous solution to separate the double-strands of the captured library, and recover the washed single-stranded library;
对单链文库进行PCR扩增。捕获效果如图1所示。参见图1,本发明方法制备的探针捕获效果和传统方法制备的探针捕获效果相比,都达到了对目的区域100%的覆盖且覆盖度较均一,而成本不足传统方法的1%。PCR amplification was performed on single-stranded libraries. The capture effect is shown in Figure 1. Referring to Fig. 1, compared with the probe capture effect prepared by the traditional method, the probe capture effect prepared by the method of the present invention has achieved 100% coverage of the target area and the coverage is relatively uniform, while the cost is less than 1% of the traditional method.
本发明最大的优点是能在保证捕获效率和特异性的前提下,大大降低探针制备成本。以2012年发表在Science translational medicine上的一篇学术论文为例,文中合成探针的目标合成区域约4.1Mbp。按照文中描述,粗略计算仅合成探针的花费将超过1200万元人民币。而用本发明的方法,制备同样的探针所需不足10万元人民币,且捕获效果与之相当。The greatest advantage of the present invention is that it can greatly reduce the cost of probe preparation under the premise of ensuring capture efficiency and specificity. Taking an academic paper published on Science translational medicine in 2012 as an example, the target synthesis region of the synthesized probe in the paper is about 4.1Mbp. According to the description in the article, a rough calculation will only cost more than 12 million yuan for the synthesis of probes. However, with the method of the present invention, less than 100,000 RMB is needed to prepare the same probe, and the capture effect is equivalent to it.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410464934.0A CN104278022B (en) | 2014-09-12 | 2014-09-12 | A kind of preparation method and application of DNA capture probes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410464934.0A CN104278022B (en) | 2014-09-12 | 2014-09-12 | A kind of preparation method and application of DNA capture probes |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104278022A CN104278022A (en) | 2015-01-14 |
CN104278022B true CN104278022B (en) | 2017-03-15 |
Family
ID=52253368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410464934.0A Active CN104278022B (en) | 2014-09-12 | 2014-09-12 | A kind of preparation method and application of DNA capture probes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104278022B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106591285B (en) * | 2015-10-19 | 2019-11-29 | 浙江安诺优达生物科技有限公司 | A method of constructing the library Hi-C of high availability data rate |
CN105671176A (en) * | 2016-03-16 | 2016-06-15 | 北京迈基诺基因科技有限责任公司 | Probe set and kit for detecting ALK fusion breaking point |
CN105779590A (en) * | 2016-03-16 | 2016-07-20 | 北京迈基诺基因科技有限责任公司 | Capture probe set and kit for detecting human mitochondrial genes |
CN106591288A (en) * | 2016-12-13 | 2017-04-26 | 上海美迪维康生物科技有限公司 | Second-generation sequencing library building technology based on probe capturing |
CN107236727B (en) * | 2017-05-31 | 2021-09-14 | 江苏为真生物医药技术股份有限公司 | Preparation method of single-stranded probe for polygene capture sequencing |
CN109486925A (en) * | 2018-11-27 | 2019-03-19 | 江苏苏博生物医学科技南京有限公司 | A technique for self-control 11 gene of probe in detecting tumour |
CN109609610A (en) * | 2018-11-27 | 2019-04-12 | 江苏苏博生物医学科技南京有限公司 | A method of self-control probe in detecting BRCA gene |
CN109810973A (en) * | 2019-03-19 | 2019-05-28 | 深圳因合生物科技有限公司 | A method of gDNA simulation cfDNA is interrupted using ultrasonic wave |
CN110305945A (en) * | 2019-07-09 | 2019-10-08 | 中国人民解放军第四军医大学 | A mutation detection technology of cell-free mitochondrial DNA based on next-generation sequencing technology |
US20210032702A1 (en) * | 2019-07-31 | 2021-02-04 | The General Hospital Corporation | Lineage inference from single-cell transcriptomes |
CN113122612B (en) * | 2019-12-31 | 2023-06-27 | 深圳华大智造科技股份有限公司 | Preparation method and application of DNA capture probe for capturing and sequencing target area |
CN113046346A (en) * | 2021-03-18 | 2021-06-29 | 深圳人体密码基因科技有限公司 | Preparation method of genome capture probe |
CN114480739A (en) * | 2022-02-18 | 2022-05-13 | 武汉凯德维斯医学检验实验室有限公司 | Method for preparing human papilloma virus capture probe set and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1712544A (en) * | 2004-06-14 | 2005-12-28 | 蔡剑平 | Magnetic capture of SARS coronary virus and PCR detection therewith |
CN101864489A (en) * | 2010-06-09 | 2010-10-20 | 北京大学 | A method for enriching exogenous DNA in transgenic products |
CN102839168A (en) * | 2012-07-31 | 2012-12-26 | 深圳华大基因研究院 | Nucleic acid probe, and preparation method and application thereof |
-
2014
- 2014-09-12 CN CN201410464934.0A patent/CN104278022B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1712544A (en) * | 2004-06-14 | 2005-12-28 | 蔡剑平 | Magnetic capture of SARS coronary virus and PCR detection therewith |
CN101864489A (en) * | 2010-06-09 | 2010-10-20 | 北京大学 | A method for enriching exogenous DNA in transgenic products |
CN102839168A (en) * | 2012-07-31 | 2012-12-26 | 深圳华大基因研究院 | Nucleic acid probe, and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN104278022A (en) | 2015-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104278022B (en) | A kind of preparation method and application of DNA capture probes | |
CN102329876B (en) | Method for measuring nucleotide sequence of disease associated nucleic acid molecules in sample to be detected | |
JP4480715B2 (en) | Double-end sequencing | |
ES2533461T3 (en) | Determination of the abundance of messages and the number of copies of alleles using IVT with single-strand primer-promoter-selector constructs | |
TWI626315B (en) | DNA 5-methylcytosine and 5-hydroxymethylcytosine gene mapping method | |
CN102409047B (en) | Method for building sequencing library by hybridization | |
CN102409042B (en) | High throughput genome methylated DNA enrichment method and indexes and index adapters used in same | |
CN103806111A (en) | Construction method and application of high-throughout sequencing library | |
CN102796808A (en) | Methylation high-flux detection method | |
CN103103624A (en) | Method for establishing high-throughput sequencing library and application thereof | |
CN110760936B (en) | Method for constructing DNA methylation library and its application | |
CN113748216B (en) | A single-channel sequencing method based on spontaneous luminescence | |
CN104250663A (en) | High-flux sequencing detection method of methylated Cpg islands | |
CN105821138A (en) | Method for constructing double-stem-loop structure DNA template to detect nucleic acid based on ligation reaction | |
JP2017533709A (en) | Sequencing from multiple primers to increase data speed and density | |
US20090023151A1 (en) | Method For The Labeling And Detection Of Small Polynucleotides | |
CN113166809B (en) | DNA methylation detection method, kit, device and application | |
CN107858409B (en) | Methylation library-building sequencing method for micro-degradation genome DNA and kit thereof | |
CN102533944B (en) | Hemi methylation connector for enrichment and sequencing of methylation deoxyribonucleic acid (DNA) and application thereof | |
CN109234357B (en) | Method, primer combination, kit and application for detecting fusion mutation of target gene | |
JP2003517303A (en) | Controllable implementation of multiplex PCR amplification | |
TW201321566A (en) | Method and system for determining the status of health of a human subject | |
TW201321520A (en) | Method and system for virus detection | |
CN112359143A (en) | Isothermal index amplification method based on Y-type probe set and application thereof | |
CN103451265A (en) | Method for capturing single molecular template DNA by microporous array solid-liquid phase under action of electric field |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |